secwatch.observer — SEC 8-K summary
======================================

Issuer:     DAVITA INC. (DVA)
CIK:        0000927066
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0000927066-23-000175
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DaVita reports Q2 2023 revenue of $3.0B; diluted EPS $1.91, adjusted EPS $2.08
------------------------------------------------------------------------------

- Consolidated revenue $3.0B; operating income $405M; adjusted operating income $432M.
- Diluted GAAP EPS $1.91; adjusted diluted EPS $2.08; free cash flow $260M.
- Refinanced existing term loan and revolver with new $1.25B Term Loan A-1 and $1.5B revolver.
- Six-month net income $294M vs $387M in prior year, a 24% decline.
- CEO highlights strong clinical innovation and operational improvements; reaffirms full-year outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927066/000092706623000175/0000927066-23-000175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927066/000092706623000175/dva-20230803.htm
  HTML page:      https://secwatch.observer/filing/0000927066-23-000175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer